IGM Biosciences Overview
IGM Biosciences Target Price
Analysts' 12-month price predictions for IGMS.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.27
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-01-10 | Truist FinancialAsthika Goonewardene | $2 |  57.5% upside |  |
| 2025-01-10 | RBC CapitalBrian Abrahams | $1.5 | 18.1% upside | |
| 2024-12-05 | BMO CapitalEtzer Darout | $21 | 1553.5% upside | |
| 2024-10-01 | RBC CapitalBrian Abrahams | $17 | 1238.6% upside | |
| 2024-10-01 | Stifel NicolausStephen Willey | $25 | 1868.5% upside | |
| 2024-10-01 | Truist FinancialAsthika Goonewardene | $12 | 844.9% upside | |
| 2024-08-15 | WedbushRobert Driscoll | $25 | 1868.5% upside | |
| 2024-08-14 | Morgan StanleyMichael Ulz | $12 | 844.9% upside | |
| 2024-05-09 | RBC CapitalBrian Abrahams | $20 | 1474.8% upside | |
| 2022-08-23 | Truist Financial | $37 | 2813.4% upside | |
| 2022-06-20 | Robert W. BairdJoel Beatty | $31 | 2340.9% upside | |
| 2022-03-30 | Truist FinancialAsthika Goonewardene | $74 | 5726.8% upside | |